RxDoctor Payments Data

Hiral Jani, PA

Physician Assistant · Metuchen, NJNPI 1306579354

Payments from drug & device makers

$7,266in general payments, 2019–2025

Across 440 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Bayer$936
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$675
  • Novo Nordisk$525
  • Corcept Therapeutics$484
  • Amgen$476
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$7,266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,266 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$20,620
Medicare patients
135
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methenamine Hippurate12$1,170
Oxybutynin Chloride ErOxybutynin Chloride13$1,015
Levothyroxine Sodium43$641
Albuterol Sulfate HfaAlbuterol Sulfate29$613
Omeprazole21$608
Rosuvastatin Calcium39$573
Diclofenac Sodium17$482
Atorvastatin Calcium60$384
Amlodipine Besylate40$380
Pantoprazole Sodium19$369
Gabapentin27$342
Methylprednisolone32$253
Fluticasone Propionate11$229
Zolpidem Tartrate26$210
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$268$013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Metuchen

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →